INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-2189405678-GLP-1-obesity]( "Glucagon-Like Peptide-1 (GLP-1) Analogues Applications Notebook")
Glucagon-Like Peptide-1 (GLP-1) Analogues Applications NotebookView this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.
-
![Adeno-associated viruses AAV GettyImages-1322096218]( "Scale-Up Of A Transient rAAV Production Process")
Scale-Up Of A Transient rAAV Production ProcessScalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.
-
![Unleashing The Potential For Polyvinyl Alcohol In Spray Drying For Oral Solid Dosage Forms]( "Unleash The Potential For Polyvinyl Alcohol In Spray Drying")
Unleash The Potential For Polyvinyl Alcohol In Spray DryingDiscover how polyvinyl alcohol (PVA) addresses key formulation challenges in oral solid dosage forms to enhance solubility and stability across diverse APIs, which include emerging drug classes like PROTACs.
-
![Accelerate Your pDNA And mRNA Process Development]( "Accelerate Your pDNA And mRNA Process Development")
Accelerate Your pDNA And mRNA Process DevelopmentExplore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
-
Utilizing The Colon Intestine-Chip To Investigate Mechanisms Of Gastrointestinal Disease8/2/2024
What are the application and benefits of Organ-Chips and what makes them superior to organoids in the study of GI-related diseases?
-
Rheological Properties Of Pharmaceutical Excipients: Lactose Monohydrate And Carboxymethyl Cellulose12/30/2024
Explore lactose monohydrate and CMC rheology, highlighting their flow, cohesion, and compressibility properties to optimize pharmaceutical formulations under varying stress and temperature conditions.
-
Enhancing Throughput And Reproducibility In Proteomic Analysis8/27/2025
Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.
-
Using DSC And MDSC To Study Material Interactions Of APIs And Excipients1/7/2026
Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.
-
Assessment Of Compound Toxicity Effects With High-Content Imaging3/17/2025
3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.
DRUG DEVELOPMENT SOLUTIONS
-
![Cytiva Allegro Connect Virus Filtration System]( "Single-Use Automated Virus Filtration System")
Learn about a single-use automated filtration system designed to deliver robust process control during this critical downstream step.
-
![Thermo Fisher]( "Single-Use Chromatography System For Advanced Downstream Bioprocessing")
CDMOs, CMOs, and those working on pilot to scale-up operations can benefit from this single-use solution for chromatographic purification that offers easy integration and versatility in scale.
-
![GettyImages-1306664598 lab research]( "Psychedelics: Drug Development Capabilities")
Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.
-
![GettyImages-1302287478-powder-excipient-petri-dish]( "Unlock Amorphous Solubility Enhancement For Challenging Compounds")
Enhance drug solubility and bioavailability with an advanced mesoporous silica excipient that stabilizes poorly soluble compounds in their amorphous form and is backed by strong regulatory and quality support.
-
![GettyImages-1869998947-doctor-patient]( "Translational Pharmaceutics® For First-In-Human Studies")
Re-engineer your drug's path into clinical development and accelerate time to Proof-of-Concept. Real-time data guides rapid formulation iterations, minimizing drug substance use and lowering program risk.
